TABLE-AnGes MG <4563.T>-9-mth group results

Nov 6 (Reuters) -

ANGES MG INC

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

9 months ended 9 months ended

Sep 30, 2009 Sep 30, 2008

LATEST YEAR-AGO

RESULTS RESULTS
Sales 489 mln 701 mln

(-36.3 pct)
Operating loss 2.08 loss 2.29
Recurring loss 2.25 loss 2.13
Net loss 2.39 loss 2.90
EPS loss Y20,300.85 loss Y24,699.06

NOTE - AnGes MG Inc is engaged in research and development of pharmaceutical products.

For latest earnings estimates made by Toyo Keizai, please
double click on 4563.TK1.